title: Ceramide glycosylation catalyzed by glucosylceramide synthase and cancer drug resistance.
abstract: Glucosylceramide synthase (GCS), converting ceramide to glucosylceramide, catalyzes the first reaction of ceramide glycosylation in sphingolipid metabolism. This glycosylation by GCS is a critical step regulating the modulation of cellular activities by controlling ceramide and glycosphingolipids (GSLs). An increase of ceramide in response to stresses, such as chemotherapy, drives cells to proliferation arrest and apoptosis or autophagy; however, ceramide glycosylation promptly eliminates ceramide and consequently, these induced processes, thus protecting cancer cells. Further, persistently enhanced ceramide glycosylation can increase GSLs, participating in selecting cancer cells to drug resistance. GCS is overexpressed in diverse drug-resistant cancer cells and in tumors of breast, colon, and leukemia that display poor response to chemotherapy. As ceramide glycosylation by GCS is a rate-limiting step in GSL synthesis, inhibition of GCS sensitizes cancer cells to anticancer drugs and eradicates cancer stem cells. Mechanistic studies indicate that uncoupling ceramide glycosylation can modulate gene expression, decreasing MDR1 through the cSrc/β-catenin pathway and restoring p53 expression via RNA splicing. These studies not only expand our knowledge in understanding how ceramide glycosylation affects cancer cells but also provide novel therapeutic approaches for targeting refractory tumors.
authors.affiliation: Department of Basic Pharmaceutical Sciences, University of Louisiana at Monroe, Monroe, LA, USA. yliu@ulm.edu
authors.forename: Yong-Yu
authors.initials: YY
authors.lastname: Liu
authors.forename: Ronald A
authors.initials: RA
authors.lastname: Hill
authors.forename: Yu-Teh
authors.initials: YT
authors.lastname: Li
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002518:Ceramides / Q000378:metabolism*; D019008:Drug Resistance, Neoplasm; D005964:Glucosyltransferases / Q000378:metabolism*; D006031:Glycosylation; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology*
chemical_list: D000970:Antineoplastic Agents; D002518:Ceramides; D005964:Glucosyltransferases; C023246:ceramide glucosyltransferase